Yuki Ishii

866 total citations
29 papers, 703 citations indexed

About

Yuki Ishii is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yuki Ishii has authored 29 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Hematology. Recurrent topics in Yuki Ishii's work include Retinoids in leukemia and cellular processes (10 papers), Acute Myeloid Leukemia Research (7 papers) and Ubiquitin and proteasome pathways (5 papers). Yuki Ishii is often cited by papers focused on Retinoids in leukemia and cellular processes (10 papers), Acute Myeloid Leukemia Research (7 papers) and Ubiquitin and proteasome pathways (5 papers). Yuki Ishii collaborates with scholars based in Japan, United States and United Kingdom. Yuki Ishii's co-authors include Yoshio Honma, Shingo Sakai, Doris Germain, Samuel Waxman, Ken‐ichi Asahi, Hiromasa Kiyota, Takashi Kasukabe, Takeshi Sassa, Jean Y. J. Wang and Richard D. Kolodner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Yuki Ishii

28 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Ishii Japan 17 524 139 74 72 67 29 703
S.H. Olesen United States 13 738 1.4× 231 1.7× 139 1.9× 79 1.1× 31 0.5× 15 1000
Baoxu Pang Netherlands 12 710 1.4× 232 1.7× 58 0.8× 108 1.5× 112 1.7× 16 1000
Walter Bardenheuer Germany 18 509 1.0× 292 2.1× 53 0.7× 99 1.4× 93 1.4× 37 848
Sen Zhang China 11 795 1.5× 161 1.2× 38 0.5× 83 1.2× 75 1.1× 24 1.0k
Yumiko Hirokawa Australia 19 528 1.0× 271 1.9× 54 0.7× 61 0.8× 51 0.8× 31 910
Thomas Ulshöfer Germany 14 249 0.5× 61 0.4× 88 1.2× 86 1.2× 80 1.2× 33 601
Shuyun Rao United States 13 526 1.0× 157 1.1× 19 0.3× 124 1.7× 65 1.0× 24 722
Pattabhiraman Shankaranarayanan France 14 531 1.0× 102 0.7× 67 0.9× 104 1.4× 134 2.0× 17 770
Brandon White United States 11 653 1.2× 113 0.8× 20 0.3× 45 0.6× 42 0.6× 18 791

Countries citing papers authored by Yuki Ishii

Since Specialization
Citations

This map shows the geographic impact of Yuki Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Ishii more than expected).

Fields of papers citing papers by Yuki Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Ishii. The network helps show where Yuki Ishii may publish in the future.

Co-authorship network of co-authors of Yuki Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Ishii. A scholar is included among the top collaborators of Yuki Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Ishii. Yuki Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishii, Yuki, David R. Pearce, Kyren A. Lazarus, et al.. (2025). Compound screening in human airway basal cells identifies Wnt pathway activators as potential pro-regenerative therapies. Journal of Cell Science. 138(7).
2.
3.
Ishii, Yuki, Krishna K. Kolluri, Adam Pennycuick, et al.. (2021). BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma. Journal of Biological Chemistry. 297(5). 101223–101223. 9 indexed citations
4.
Alrifai, Doraid, Krishna K. Kolluri, Elizabeth K. Sage, et al.. (2018). Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma. Lung Cancer. 127. 164–166. 12 indexed citations
5.
Ishii, Yuki, Jonathan D. Cheng, Michele Massimino, et al.. (2015). Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release. PLoS ONE. 10(10). e0140585–e0140585. 20 indexed citations
6.
Suknuntha, Kran, Yuki Ishii, Kejin Hu, et al.. (2015). Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells. Stem Cell Research. 15(3). 678–693. 25 indexed citations
7.
Suknuntha, Kran, Yuki Ishii, Kejin Hu, et al.. (2014). Induced Pluripotent Stem Cell Model of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As a Novel Survival Factor for Primitive Leukemia Cells. Blood. 124(21). 397–397. 1 indexed citations
8.
Ishii, Yuki, Luena Papa, Zhenyu Yue, et al.. (2011). Bortezomib Enhances the Efficacy of Fulvestrant by Amplifying the Aggregation of the Estrogen Receptor, Which Leads to a Proapoptotic Unfolded Protein Response. Clinical Cancer Research. 17(8). 2292–2300. 26 indexed citations
9.
Suknuntha, Kran, et al.. (2011). Modeling CML Development and Drug Resistance Using iPSC Technology,. Blood. 118(21). 3767–3767. 1 indexed citations
10.
11.
Ishii, Yuki, Samuel Waxman, & Doris Germain. (2007). Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 7(3). 359–365. 28 indexed citations
12.
Ishii, Yuki, Takashi Kasukabe, & Yoshio Honma. (2005). Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1745(2). 156–165. 27 indexed citations
13.
Ishii, Yuki, Takashi Kasukabe, & Yoshio Honma. (2005). Induction of CCAAT/enhancer binding protein‐δ by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells. British Journal of Haematology. 128(4). 540–547. 14 indexed citations
14.
Ishii, Yuki, Hiromasa Kiyota, Shingo Sakai, & Yoshio Honma. (2004). Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones. Leukemia. 18(8). 1413–1419. 52 indexed citations
15.
Honma, Yoshio, Yuki Ishii, Takeshi Sassa, & Ken‐ichi Asahi. (2003). Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells. Leukemia Research. 27(11). 1019–1025. 27 indexed citations
16.
Ishii, Yuki, Shingo Sakai, & Yoshio Honma. (2003). Cytokinin-induced differentiation of human myeloid leukemia HL-60 cells is associated with the formation of nucleotides, but not with incorporation into DNA or RNA. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1643(1-3). 11–24. 37 indexed citations
17.
Honma, Yoshio, Yuki Ishii, Yuri Yamamoto-Yamaguchi, Takeshi Sassa, & Ken‐ichi Asahi. (2003). Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice.. PubMed. 63(13). 3659–66. 45 indexed citations
18.
Honma, Yoshio & Yuki Ishii. (2002). Differentiation of Human Myeloid Leukemia Cells by Plant Redifferentiation-inducing Hormones. Leukemia & lymphoma. 43(9). 1729–1735. 16 indexed citations
19.
Niitsu, Nozomi, Yuki Ishii, Akira Matsuda, & Yoshio Honma. (2001). Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.. PubMed. 61(1). 178–85. 13 indexed citations
20.
Honma, Yoshio, Yuki Ishii, Takashi Kasukabe, et al.. (2001). Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives. Experimental Hematology. 29(2). 194–201. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.H. Olesen Breakdown of academic impact, for papers by Baoxu Pang Breakdown of academic impact, for papers by Walter Bardenheuer Breakdown of academic impact, for papers by Sen Zhang Breakdown of academic impact, for papers by Yumiko Hirokawa Breakdown of academic impact, for papers by Thomas Ulshöfer Breakdown of academic impact, for papers by Shuyun Rao Breakdown of academic impact, for papers by Pattabhiraman Shankaranarayanan Breakdown of academic impact, for papers by Brandon White
Rankless by CCL
2026